Cannabis-based Medicines Market, Global Outlook and Forecast 2022-2028

March 2022 | 64 pages | ID: C82436B34D6BEN
Market Monitor Global

Abstracts

Marijuana (medical cannabis) is used to treat nausea, pain, anxiety, MS, insomnia, epilepsy, and other conditions. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the main chemicals used in medicine. In the medicines market, Epidiolex, the first cannabis-based medication approved by the US Food and Drug Administration.

This report contains market size and forecasts of Cannabis-based Medicines in Global, including the following market information:

Global Cannabis-based Medicines Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cannabis-based Medicines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

CBD (Cannabidiol) Based Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cannabis-based Medicines include GW Pharmaceuticals plc, INSYS Therapeutics, Aequus Pharmaceuticals, Axim Biotechnologies, Revive Therapeutics, MGC Pharmaceuticals and ECHO Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cannabis-based Medicines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cannabis-based Medicines Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cannabis-based Medicines Market Segment Percentages, by Type, 2021 (%)

• CBD (Cannabidiol) Based
• THC (Tetrahydrocannabinol) Based
• Others

Global Cannabis-based Medicines Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cannabis-based Medicines Market Segment Percentages, by Application, 2021 (%)

• Oral Solution
• Tablets
• Patches
• Others

Global Cannabis-based Medicines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cannabis-based Medicines Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cannabis-based Medicines revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cannabis-based Medicines revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GW Pharmaceuticals plc
• INSYS Therapeutics
• Aequus Pharmaceuticals
• Axim Biotechnologies
• Revive Therapeutics
• MGC Pharmaceuticals
• ECHO Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cannabis-based Medicines Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cannabis-based Medicines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CANNABIS-BASED MEDICINES OVERALL MARKET SIZE

2.1 Global Cannabis-based Medicines Market Size: 2021 VS 2028
2.2 Global Cannabis-based Medicines Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cannabis-based Medicines Players in Global Market
3.2 Top Global Cannabis-based Medicines Companies Ranked by Revenue
3.3 Global Cannabis-based Medicines Revenue by Companies
3.4 Top 3 and Top 5 Cannabis-based Medicines Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cannabis-based Medicines Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cannabis-based Medicines Players in Global Market
  3.6.1 List of Global Tier 1 Cannabis-based Medicines Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cannabis-based Medicines Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cannabis-based Medicines Market Size Markets, 2021 & 2028
  4.1.2 CBD (Cannabidiol) Based
  4.1.3 THC (Tetrahydrocannabinol) Based
  4.1.4 Others
4.2 By Type - Global Cannabis-based Medicines Revenue & Forecasts
  4.2.1 By Type - Global Cannabis-based Medicines Revenue, 2017-2022
  4.2.2 By Type - Global Cannabis-based Medicines Revenue, 2023-2028
  4.2.3 By Type - Global Cannabis-based Medicines Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cannabis-based Medicines Market Size, 2021 & 2028
  5.1.2 Oral Solution
  5.1.3 Tablets
  5.1.4 Patches
  5.1.5 Others
5.2 By Application - Global Cannabis-based Medicines Revenue & Forecasts
  5.2.1 By Application - Global Cannabis-based Medicines Revenue, 2017-2022
  5.2.2 By Application - Global Cannabis-based Medicines Revenue, 2023-2028
  5.2.3 By Application - Global Cannabis-based Medicines Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cannabis-based Medicines Market Size, 2021 & 2028
6.2 By Region - Global Cannabis-based Medicines Revenue & Forecasts
  6.2.1 By Region - Global Cannabis-based Medicines Revenue, 2017-2022
  6.2.2 By Region - Global Cannabis-based Medicines Revenue, 2023-2028
  6.2.3 By Region - Global Cannabis-based Medicines Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cannabis-based Medicines Revenue, 2017-2028
  6.3.2 US Cannabis-based Medicines Market Size, 2017-2028
  6.3.3 Canada Cannabis-based Medicines Market Size, 2017-2028
  6.3.4 Mexico Cannabis-based Medicines Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cannabis-based Medicines Revenue, 2017-2028
  6.4.2 Germany Cannabis-based Medicines Market Size, 2017-2028
  6.4.3 France Cannabis-based Medicines Market Size, 2017-2028
  6.4.4 U.K. Cannabis-based Medicines Market Size, 2017-2028
  6.4.5 Italy Cannabis-based Medicines Market Size, 2017-2028
  6.4.6 Russia Cannabis-based Medicines Market Size, 2017-2028
  6.4.7 Nordic Countries Cannabis-based Medicines Market Size, 2017-2028
  6.4.8 Benelux Cannabis-based Medicines Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cannabis-based Medicines Revenue, 2017-2028
  6.5.2 China Cannabis-based Medicines Market Size, 2017-2028
  6.5.3 Japan Cannabis-based Medicines Market Size, 2017-2028
  6.5.4 South Korea Cannabis-based Medicines Market Size, 2017-2028
  6.5.5 Southeast Asia Cannabis-based Medicines Market Size, 2017-2028
  6.5.6 India Cannabis-based Medicines Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cannabis-based Medicines Revenue, 2017-2028
  6.6.2 Brazil Cannabis-based Medicines Market Size, 2017-2028
  6.6.3 Argentina Cannabis-based Medicines Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cannabis-based Medicines Revenue, 2017-2028
  6.7.2 Turkey Cannabis-based Medicines Market Size, 2017-2028
  6.7.3 Israel Cannabis-based Medicines Market Size, 2017-2028
  6.7.4 Saudi Arabia Cannabis-based Medicines Market Size, 2017-2028
  6.7.5 UAE Cannabis-based Medicines Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GW Pharmaceuticals plc
  7.1.1 GW Pharmaceuticals plc Corporate Summary
  7.1.2 GW Pharmaceuticals plc Business Overview
  7.1.3 GW Pharmaceuticals plc Cannabis-based Medicines Major Product Offerings
  7.1.4 GW Pharmaceuticals plc Cannabis-based Medicines Revenue in Global Market (2017-2022)
  7.1.5 GW Pharmaceuticals plc Key News
7.2 INSYS Therapeutics
  7.2.1 INSYS Therapeutics Corporate Summary
  7.2.2 INSYS Therapeutics Business Overview
  7.2.3 INSYS Therapeutics Cannabis-based Medicines Major Product Offerings
  7.2.4 INSYS Therapeutics Cannabis-based Medicines Revenue in Global Market (2017-2022)
  7.2.5 INSYS Therapeutics Key News
7.3 Aequus Pharmaceuticals
  7.3.1 Aequus Pharmaceuticals Corporate Summary
  7.3.2 Aequus Pharmaceuticals Business Overview
  7.3.3 Aequus Pharmaceuticals Cannabis-based Medicines Major Product Offerings
  7.3.4 Aequus Pharmaceuticals Cannabis-based Medicines Revenue in Global Market (2017-2022)
  7.3.5 Aequus Pharmaceuticals Key News
7.4 Axim Biotechnologies
  7.4.1 Axim Biotechnologies Corporate Summary
  7.4.2 Axim Biotechnologies Business Overview
  7.4.3 Axim Biotechnologies Cannabis-based Medicines Major Product Offerings
  7.4.4 Axim Biotechnologies Cannabis-based Medicines Revenue in Global Market (2017-2022)
  7.4.5 Axim Biotechnologies Key News
7.5 Revive Therapeutics
  7.5.1 Revive Therapeutics Corporate Summary
  7.5.2 Revive Therapeutics Business Overview
  7.5.3 Revive Therapeutics Cannabis-based Medicines Major Product Offerings
  7.5.4 Revive Therapeutics Cannabis-based Medicines Revenue in Global Market (2017-2022)
  7.5.5 Revive Therapeutics Key News
7.6 MGC Pharmaceuticals
  7.6.1 MGC Pharmaceuticals Corporate Summary
  7.6.2 MGC Pharmaceuticals Business Overview
  7.6.3 MGC Pharmaceuticals Cannabis-based Medicines Major Product Offerings
  7.6.4 MGC Pharmaceuticals Cannabis-based Medicines Revenue in Global Market (2017-2022)
  7.6.5 MGC Pharmaceuticals Key News
7.7 ECHO Pharmaceuticals
  7.7.1 ECHO Pharmaceuticals Corporate Summary
  7.7.2 ECHO Pharmaceuticals Business Overview
  7.7.3 ECHO Pharmaceuticals Cannabis-based Medicines Major Product Offerings
  7.7.4 ECHO Pharmaceuticals Cannabis-based Medicines Revenue in Global Market (2017-2022)
  7.7.5 ECHO Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cannabis-based Medicines Market Opportunities & Trends in Global Market
Table 2. Cannabis-based Medicines Market Drivers in Global Market
Table 3. Cannabis-based Medicines Market Restraints in Global Market
Table 4. Key Players of Cannabis-based Medicines in Global Market
Table 5. Top Cannabis-based Medicines Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cannabis-based Medicines Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cannabis-based Medicines Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cannabis-based Medicines Product Type
Table 9. List of Global Tier 1 Cannabis-based Medicines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cannabis-based Medicines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cannabis-based Medicines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cannabis-based Medicines Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cannabis-based Medicines Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cannabis-based Medicines Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cannabis-based Medicines Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cannabis-based Medicines Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cannabis-based Medicines Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cannabis-based Medicines Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cannabis-based Medicines Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cannabis-based Medicines Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cannabis-based Medicines Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cannabis-based Medicines Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cannabis-based Medicines Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cannabis-based Medicines Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cannabis-based Medicines Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cannabis-based Medicines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cannabis-based Medicines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cannabis-based Medicines Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cannabis-based Medicines Revenue, (US$, Mn), 2023-2028
Table 30. GW Pharmaceuticals plc Corporate Summary
Table 31. GW Pharmaceuticals plc Cannabis-based Medicines Product Offerings
Table 32. GW Pharmaceuticals plc Cannabis-based Medicines Revenue (US$, Mn), (2017-2022)
Table 33. INSYS Therapeutics Corporate Summary
Table 34. INSYS Therapeutics Cannabis-based Medicines Product Offerings
Table 35. INSYS Therapeutics Cannabis-based Medicines Revenue (US$, Mn), (2017-2022)
Table 36. Aequus Pharmaceuticals Corporate Summary
Table 37. Aequus Pharmaceuticals Cannabis-based Medicines Product Offerings
Table 38. Aequus Pharmaceuticals Cannabis-based Medicines Revenue (US$, Mn), (2017-2022)
Table 39. Axim Biotechnologies Corporate Summary
Table 40. Axim Biotechnologies Cannabis-based Medicines Product Offerings
Table 41. Axim Biotechnologies Cannabis-based Medicines Revenue (US$, Mn), (2017-2022)
Table 42. Revive Therapeutics Corporate Summary
Table 43. Revive Therapeutics Cannabis-based Medicines Product Offerings
Table 44. Revive Therapeutics Cannabis-based Medicines Revenue (US$, Mn), (2017-2022)
Table 45. MGC Pharmaceuticals Corporate Summary
Table 46. MGC Pharmaceuticals Cannabis-based Medicines Product Offerings
Table 47. MGC Pharmaceuticals Cannabis-based Medicines Revenue (US$, Mn), (2017-2022)
Table 48. ECHO Pharmaceuticals Corporate Summary
Table 49. ECHO Pharmaceuticals Cannabis-based Medicines Product Offerings
Table 50. ECHO Pharmaceuticals Cannabis-based Medicines Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cannabis-based Medicines Segment by Type in 2021
Figure 2. Cannabis-based Medicines Segment by Application in 2021
Figure 3. Global Cannabis-based Medicines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cannabis-based Medicines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cannabis-based Medicines Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cannabis-based Medicines Revenue in 2021
Figure 8. By Type - Global Cannabis-based Medicines Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cannabis-based Medicines Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cannabis-based Medicines Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cannabis-based Medicines Revenue Market Share, 2017-2028
Figure 12. US Cannabis-based Medicines Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cannabis-based Medicines Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cannabis-based Medicines Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cannabis-based Medicines Revenue Market Share, 2017-2028
Figure 16. Germany Cannabis-based Medicines Revenue, (US$, Mn), 2017-2028
Figure 17. France Cannabis-based Medicines Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cannabis-based Medicines Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cannabis-based Medicines Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cannabis-based Medicines Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cannabis-based Medicines Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cannabis-based Medicines Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cannabis-based Medicines Revenue Market Share, 2017-2028
Figure 24. China Cannabis-based Medicines Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cannabis-based Medicines Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cannabis-based Medicines Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cannabis-based Medicines Revenue, (US$, Mn), 2017-2028
Figure 28. India Cannabis-based Medicines Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cannabis-based Medicines Revenue Market Share, 2017-2028
Figure 30. Brazil Cannabis-based Medicines Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cannabis-based Medicines Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cannabis-based Medicines Revenue Market Share, 2017-2028
Figure 33. Turkey Cannabis-based Medicines Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cannabis-based Medicines Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cannabis-based Medicines Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cannabis-based Medicines Revenue, (US$, Mn), 2017-2028
Figure 37. GW Pharmaceuticals plc Cannabis-based Medicines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. INSYS Therapeutics Cannabis-based Medicines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Aequus Pharmaceuticals Cannabis-based Medicines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Axim Biotechnologies Cannabis-based Medicines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Revive Therapeutics Cannabis-based Medicines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. MGC Pharmaceuticals Cannabis-based Medicines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. ECHO Pharmaceuticals Cannabis-based Medicines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)